Medicine and Dentistry
Inflammatory Bowel Disease
100%
Patient
99%
Crohn's Disease
63%
Spontaneous Remission
41%
Mercaptopurine
36%
Ulcerative Colitis
36%
Association
33%
Combination Therapy
28%
Infliximab
25%
Adalimumab
25%
Chemotherapeutic Agent
24%
Drug
24%
Relapse
23%
Tioguanine
23%
Hospital
21%
Disease Activity
20%
Tumor Necrosis Factor
20%
Experience
18%
Monitoring
18%
Colitis
18%
Disease
17%
Deep Vein Thrombosis
16%
Young Adult
16%
Patient Care
16%
Endoscopic Retrograde Cholangiopancreatography
16%
Cytotechnology
16%
Tumor Necrosis Factor
16%
Systematic Review
16%
Meta-Analysis
16%
Predictive Factor
16%
Observational Study
16%
Recurrence Risk
15%
Patient with Inflammatory Bowel Disease
12%
Nucleotide
9%
Therapeutic Procedure
9%
Drug Antibody
9%
Diagnosis
8%
Inferior Vena Cava
8%
Male
8%
Leg
8%
Retrospective Cohort Study
7%
Drug Withdrawal
7%
Patient with Crohn's Disease
7%
Metabolism
6%
Faecal Calprotectin
6%
Follow up
6%
Immunomodulating Agent
6%
Hazard Ratio
5%
Age
5%
Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
50%
Tumor Necrosis Factor
20%
Ulcerative Colitis
20%
Crohn Disease
20%
Mercaptopurine
18%
Remission
18%
Tioguanine
16%
Hot Water
16%
Drug
12%
Drug Antibody
9%
Recurrence Risk
7%
Relapse
7%
Infliximab
5%
Adalimumab
5%
Toxicity
5%
Hyperplasia
5%